Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas S Heaton

Showing results (81-90 of 82) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 82 results.
Biorxiv : the Preprint Server for Biology|August 21, 2020
The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitroTomer M Yaron, Brook E Heaton, Tyler M Levy, et al.
Science Signaling|October 25, 2022
Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replicationTomer M Yaron, Brook E Heaton, Tyler M Levy, et al.
Pageof 9

Showing results (81-90 of 82) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 82 results.
Biorxiv : the Preprint Server for Biology|August 21, 2020
The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitroTomer M Yaron, Brook E Heaton, Tyler M Levy, et al.
Science Signaling|October 25, 2022
Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replicationTomer M Yaron, Brook E Heaton, Tyler M Levy, et al.
Pageof 9